Vimarsana
Biggest News Aggregation in the World

Page 32 - Richard Pullin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Richard Pullin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Richard Pullin Today - Breaking & Trending Today

Eisai, Biogen say Alzheimer's drug succeeds in slowing cognitive decline - Vimarsana News

Eisai, Biogen say Alzheimer's drug succeeds in slowing cognitive decline

By Deena Beasley and Julie Steenhuysen (Reuters) - An experimental Alzheimer's drug developed by Eisai Co Ltd and Biogen Inc significantly slowed cogn...

Source: whbl.com
Eisai, Biogen say Alzheimer's drug succeeds in slowing cognitive decline | WSAU News/Talk 550 AM · 99.9 FM - Vimarsana News

Eisai, Biogen say Alzheimer's drug succeeds in slowing cognitive decline | WSAU News/Talk 550 AM · 99.9 FM

By Deena Beasley and Julie Steenhuysen (Reuters) - An experimental Alzheimer's drug developed by Eisai Co Ltd and Biogen Inc significantly slowed cogn...

Source: wsau.com
MMG to invest $2 billion at its troubled Peruvian Las Bambas mine - Vimarsana News

MMG to invest $2 billion at its troubled Peruvian Las Bambas mine

By Marcelo Rochabrun and Marco Aquino LIMA (Reuters) -Chinese miner MMG Ltd expects to invest $2 billion in the next five years to expand its troubled...

Source: wkzo.com
Sterling swallows bitter pill, dollar advances on hawkish Fed speak - Vimarsana News

Sterling swallows bitter pill, dollar advances on hawkish Fed speak

SINGAPORE — The pound languished near a record low on Wednesday on lingering concerns over Britain’s radical tax cuts to spur growth, while the dollar edged up…

Japan's Shionogi says COVID pill reaches Phase III milestone - Vimarsana News

Japan's Shionogi says COVID pill reaches Phase III milestone

TOKYO (Reuters) -Japan's Shionogi & Co Ltd said on Wednesday its oral treatment for COVID-19 demonstrated a significant reduction in symptoms compared with a placebo in a Phase III trial